Prevalence and determinants of pulmonary hypertension in a group of Cameroonian patients without chronic lung disease: a cross-sectional echocardiographic study

ObjectivesTo describe the sex differences in the prevalence of non-communicable diseases (NCDs) in adults aged 45 years or older in China.DesignCross-sectional study.SettingNationally representative sample of the Chinese population 2011.Participants8401 men and 8928 women over 45 years of age who participated in the first wave of the China Health and Retirement Longitudinal Study (CHARLS).Outcome measuresSelf-reported data on overall health and diagnosis of hypertension, dyslipidaemia, diabetes, heart disease, stroke, chronic lung disease, cancer or arthritis. Sex differences in NCDs were described using logistic regression to generate odds ratios (OR) with adjustment for sociodemographic factors and health-related behaviours. All analyses were stratified by age group for 45–64-year-old and ≥65-year-old participants.ResultsIn both age groups, men reported better overall health than women. The crude prevalence of heart disease, cancer and arthritis was higher while that of stroke and chronic lung disease was lower in women than in men. After adjustment, ORs (95% CI) for the 45–64 and ≥65 year age groups were 0.70 (0.58 to 0.84) and 0.66 (0.54 to 0.80), respectively, for arthritis for men compared with women. In contrast, ORs were 1.66 (1.09 to 2.52) and 2.12 (1.36 to 3.30) for stroke and 1.51 (1.21 to 1.89) and 1.43 (1.09 to 1.88) for chronic lung disease for men compared with women. ORs for heart disease (0.65 (0.52 to 0.80)) were lower in men than in women only in the 45–64 year age group.ConclusionsOdds of arthritis were lower while those of stroke and chronic lung disease were higher in men than in women in both age groups. However, odds of heart disease were lower in men than in women, but only in the group of individuals aged 45–64 years.

Download Full-text

THE CURRENT SITUATION OF TOBACCO ATTRACTION AND FACTORS RELATED TO TOBACCO CONSULTANT SERVICES, SMOKING CESSATION SERVICES AMONG PATIENTS WITH CHRONIC LUNG DISEASE AT MEDICAL CENTER NGA NĂM, SOC TRANG PROVINCE IN 2020

Tạp chí Y học Cộng đồng ◽

10.52163/vjcm.v62i6.190 ◽

2021 ◽

Vol 62 (6) ◽

Author(s):

Nguyen Thi Dao ◽

Tran Thi Ngoc Thu ◽

Phan Ngoc Thuy ◽

Nguyen Thi Hong Nguyen ◽

Nguyen Thi Mai Duyen

Keyword(s):

Smoking Cessation ◽

Lung Disease ◽

Chronic Lung Disease ◽

Medical Center ◽

Health Sector ◽

Multivariate Logistic Regression Analysis ◽

Counseling Services ◽

Related Factors ◽

Cross Sectional ◽

Smoking Cessation Services

Objectives: Determination rate of smoking and some related factors to the accessibility of counseling and smoking cessation services in patients with chronic lung disease at Nga Nam Medical Center, Soc Trang in 2020. Subjects and research methods: Cross-sectional descriptive study with analysis. The toolkit is based on “The Ministry of Health’s 2018 Tobacco Harm Prevention Guidelines” and related research. Results and discussions: The smoking rate of patients is 59.9%. The number of people accessing tobacco cessation counseling services is lowing with 29.9%. The results of multivariate logistic regression analysis showed that have relationship between the ability to access counseling services, smoking cessation and smoking (OR = 0.042; p < 0.005), gender (OR = 0.067; p < 0.005), occupation (p < 0.005). Conclusions and recommendations: Patients need to actively learn about the harmful effects of smoking as well as smoking cessation methods and services. The health sector needs to develop plans and provide counseling and smoking cessation services for patients. When educating, it is necessary to pay attention to the patient's psychology, gender and occupation.

Download Full-text

A simple echocardiographic estimate of right ventricular-arterial coupling to assess severity and outcome in pulmonary hypertension on chronic lung disease

European Respiratory Journal ◽

10.1183/13993003.02435-2018 ◽

2019 ◽

Vol 54 (3) ◽

pp. 1802435 ◽

Cited By ~ 6

Author(s):

Khodr Tello ◽

Hossein A. Ghofrani ◽

Charlotte Heinze ◽

Karsten Krueger ◽

Robert Naeije ◽

...

Keyword(s):

Pulmonary Hypertension ◽

Right Ventricular ◽

Lung Disease ◽

Chronic Lung Disease

Download Full-text

Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement

Circulation Cardiovascular Interventions ◽

10.1161/circinterventions.120.008959 ◽

2020 ◽

Vol 13 (7) ◽

Author(s):

Vincent Auffret ◽

Abdelkader Bakhti ◽

Guillaume Leurent ◽

Marc Bedossa ◽

Jacques Tomasi ◽

...

Keyword(s):

Heart Failure ◽

Pulmonary Hypertension ◽

Aortic Valve ◽

Aortic Valve Replacement ◽

Lung Disease ◽

Chronic Lung Disease ◽

Transcatheter Aortic Valve Replacement ◽

Transcatheter Aortic Valve ◽

All Cause Mortality ◽

Grade Iii

Background: Heart failure (HF) readmission is common post–transcatheter aortic valve replacement (TAVR). Nonetheless, limited data are available regarding its predictors and clinical impact. This study evaluated the incidence, predictors, and impact of HF readmission within 1-year post-TAVR, and assessed the effects of the prescription of HF therapies at discharge on the risk of HF readmission and death. Methods: Patients included in the TAVR registry of a single expert center from 2009 to 2017 were analyzed. Competing-risk and Cox regressions were performed to identify predictors of HF readmission and death. Results: Among 750 patients, 102 (13.6%) were readmitted for HF within 1-year post-TAVR. Overall, 53 patients (7.1%) experienced late readmissions (>30 days post-TAVR), and 17 (2.3%) had multiple readmissions. In ≈30% of readmissions, no trigger could be identified. Predominant causes of readmissions were changes in medication/nonadherence and supraventricular arrhythmia. Independent predictors of HF readmission included diabetes mellitus, chronic lung disease, previous acute HF, grade III or IV aortic regurgitation, and pulmonary hypertension both at discharge from the index hospitalization but not HF therapies. Overall, HF readmission did not significantly impact all-cause mortality (hazard ratio [HR], 1.36 [95% CI, 0.99–1.85]). However, late (HR, 1.90 [95% CI, 1.30–2.78]) and multiple HF readmissions (HR, 2.10 [95% CI,1.17–3.76]) were significantly associated with all-cause mortality. Prescription of renin-angiotensin system inhibitors at discharge was associated with a lower rate of all-cause mortality, especially among patients receiving doses of 25% to <50% (HR, 0.67 [95% CI, 0.48–0.94]) and 75% to 100% (HR, 0.61 [95% CI, 0.37–0.98]) of the optimal daily dose. Conclusions: HF readmission is common within 1-year of TAVR. Late and multiple HF readmissions associate with an increased risk of long-term all-cause mortality. Baseline comorbidities (diabetes, chronic lung disease, previous acute HF) and echocardiographic findings at discharge (grade III or IV aortic regurgitation, pulmonary hypertension) identified patients at high risk of HF readmission.

Download Full-text